Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three antibiotics—gentamicin, oxacillin, and piperacillin—used together for the treatment of severe or mixed bacterial infections. - **Gentamicin** is an aminoglycoside antibiotic that acts by binding to the 30S subunit of bacterial ribosomes, inhibiting protein synthesis and leading to cell death. It is particularly effective against aerobic gram-negative bacteria and shows synergistic effects when combined with beta-lactam antibiotics like penicillins[5]. - **Oxacillin** is a narrow-spectrum beta-lactam (penicillinase-resistant penicillin) antibiotic used primarily for infections caused by penicillinase-producing staphylococci (notably Staphylococcus aureus). It inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. - **Piperacillin** is an extended-spectrum ureidopenicillin that inhibits bacterial cell wall synthesis; it has broad activity against both gram-positive and gram-negative organisms, including Pseudomonas aeruginosa[1][3]. Piperacillin may be used in combination with other agents for severe or hospital-acquired infections. The rationale for combining these agents includes broadening antibacterial coverage (covering both gram-positive—including resistant staphylococci—and gram-negative pathogens), exploiting potential synergistic effects between aminoglycosides and beta-lactams, and targeting polymicrobial or high-risk hospital-acquired infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gentamicin + oxacillin + piperacillin.